Inducing strong mucosal immune responses by vaccination is important for providing protection against simian immunodeficiency virus (SIV). A replicating adenovirus type 5 host range mutant vector (Ad5hr) expressing SIV proteins induced mucosal immune responses in rectal tissue associated with delayed SIV acquisition in female rhesus macaques, but the initial mechanisms leading to the induced immunity have not been elucidated. As dendritic cells (DCs) are known to orchestrate both innate and adaptive effector immune cell responses, we investigated their role here. Rhesus macaques were immunized twice mucosally with a replicating Ad5hr expressing SIV Env, Gag, and Nef (Ad-SIV) or empty Ad5hr vector (Ad-Empty). DC subsets and their activation ...
<div><p>Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has...
Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hy...
We report on prime-boost vaccine regimens with two simian adenovirus (Ad) vectors (SAdV) or two huma...
Inducing strong mucosal immune responses by vaccination is important for providing protection agains...
Although priming with replicating adenovirus type 5 host range mutant (Ad5hr)-human immunodeficiency...
The quest for an efficacious HIV vaccine has resulted in several clinical trial failures, including ...
The quest for an efficacious HIV vaccine has resulted in several clinical trial failures, including ...
We have shown that sequential replicating adenovirus type 5 host range mutant human immunodeficiency...
AbstractWe investigated the immunogenicity and efficacy of a bimodal prime/boost vaccine regimen giv...
Information on the establishment of immunodeficiency virus infection through transmission of infecte...
HIV vaccine mediated efficacy, using an expanded live attenuated recombinant varicella virus-vectore...
AbstractPreviously, replicating adenovirus type 5 host range (Ad5hr)-HIV/SIV recombinant priming in ...
Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hy...
AbstractPreviously, priming with replication-competent adenovirus-SIV multigenic vaccines and boosti...
AbstractTo target the HIV CD4i envelope epitope, we primed rhesus macaques with replicating Ad-rhFLS...
<div><p>Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has...
Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hy...
We report on prime-boost vaccine regimens with two simian adenovirus (Ad) vectors (SAdV) or two huma...
Inducing strong mucosal immune responses by vaccination is important for providing protection agains...
Although priming with replicating adenovirus type 5 host range mutant (Ad5hr)-human immunodeficiency...
The quest for an efficacious HIV vaccine has resulted in several clinical trial failures, including ...
The quest for an efficacious HIV vaccine has resulted in several clinical trial failures, including ...
We have shown that sequential replicating adenovirus type 5 host range mutant human immunodeficiency...
AbstractWe investigated the immunogenicity and efficacy of a bimodal prime/boost vaccine regimen giv...
Information on the establishment of immunodeficiency virus infection through transmission of infecte...
HIV vaccine mediated efficacy, using an expanded live attenuated recombinant varicella virus-vectore...
AbstractPreviously, replicating adenovirus type 5 host range (Ad5hr)-HIV/SIV recombinant priming in ...
Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hy...
AbstractPreviously, priming with replication-competent adenovirus-SIV multigenic vaccines and boosti...
AbstractTo target the HIV CD4i envelope epitope, we primed rhesus macaques with replicating Ad-rhFLS...
<div><p>Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has...
Most HIV-1 infections are thought to occur at mucosal surfaces during sexual contact. It has been hy...
We report on prime-boost vaccine regimens with two simian adenovirus (Ad) vectors (SAdV) or two huma...